- Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
-
Yim HJ
- KMID: 2373119
- Clin Mol Hepatol.
- 2016 Jun;22(2):238-240.
- doi: 10.3350/cmh.2016.0103
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Undifferentiated embryonal sarcoma of the liver in an adult patient
-
Lee KH, Maratovich MN, Lee KB
- KMID: 2373128
- Clin Mol Hepatol.
- 2016 Jun;22(2):292-295.
- doi: 10.3350/cmh.2015.0102
Undifferentiated embryonal sarcoma of the liver (UESL) is rare primary hepatic sarcoma and is known to occur in pediatric patients. This case is the UESL occurred in a 51-year old... -
- CITED
-
- Close
- SHARE
-
- Close
- Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma
-
Roncalli M, Sciarra A, Tommaso LD
- KMID: 2373116
- Clin Mol Hepatol.
- 2016 Jun;22(2):199-211.
- doi: 10.3350/cmh.2016.0101
Owing to the progress of imaging techniques, benign hepatocellular nodules are increasingly discovered in the clinical practice. This group of lesions mostly arises in the context of a putatively normal... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of portal hypertension by presumed as plexiform neurofibroma at the hepatic hilum
-
Lee KH, Yoo SH, Noh GT, Heo WS, Ko BS, Chio JA, Cho HJ, Choi JY, Kim HJ, Sohn W, Park SJ, Park YM
- KMID: 2373125
- Clin Mol Hepatol.
- 2016 Jun;22(2):276-280.
- doi: 10.3350/cmh.2015.0021
Neurofibromas can occur anywhere in the body, but they usually involve the head, neck, pelvis, and extremities. Abdominal visceral involvement is rare, and intrahepatic involvement is even less common. We... -
- CITED
-
- Close
- SHARE
-
- Close
- Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm
-
An C, Rakhmonova G, Choi JY, Kim MJ
- KMID: 2373129
- Clin Mol Hepatol.
- 2016 Jun;22(2):296-307.
- doi: 10.3350/cmh.2016.0028
Liver Imaging Reporting and Data System (LI-RADS) is a system for interpreting and reporting of computed tomography and magnetic resonance imaging of the liver in patients at risk for hepatocellular... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevention of Hepatitis B reactivation in the setting of immunosuppression
-
Pattullo V
- KMID: 2373118
- Clin Mol Hepatol.
- 2016 Jun;22(2):219-237.
- doi: 10.3350/cmh.2016.0024
Advances in the treatment of malignant and inflammatory diseases have developed over time, with increasing use of chemotherapeutic and immunosuppressive agents of a range of drug classes with varying mechanism... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection
-
Nam HC, Lee HL, Yang H, Song MJ
- KMID: 2373122
- Clin Mol Hepatol.
- 2016 Jun;22(2):259-266.
- doi: 10.3350/cmh.2016.0020
BACKGROUND/AIMS: The treatment strategy for hepatitis C virus (HCV) has been changing rapidly since the introduction of direct-acting antivirals such as daclatasvir (DCV) and asunaprevir (ASV). We evaluated the efficacy... -
- CITED
-
- Close
- SHARE
-
- Close
- Current status of laparoscopic liver resection for hepatocellular carcinoma
-
Guro H, Cho JY, Han HS, Yoon YS, Choi Y, Periyasamy M
- KMID: 2373117
- Clin Mol Hepatol.
- 2016 Jun;22(2):212-218.
- doi: 10.3350/cmh.2016.0026
Laparoscopic liver resection (LLR) is becoming widely accepted for the treatment of hepatocellular carcinoma (HCC). Laparoscopic left lateral sectionectomy and minor laparoscopic liver resection are now considered standard approaches, especially... -
- CITED
-
- Close
- SHARE
-
- Close
- Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
-
Park SW, Um SH, Lee HA, Kim SH, Sim Y, Yim SY, Seo YS, Ryu HS
- KMID: 2373126
- Clin Mol Hepatol.
- 2016 Jun;22(2):281-285.
- doi: 10.3350/cmh.2015.0040
Autoimmune hepatitis (AIH) is an immune-mediated chronic liver disease characterized by hepatocellular inflammation, necrosis, and fibrosis, which can progress to cirrhosis and fulminant hepatic failure. The standard treatment for AIH... -
- CITED
-
- Close
- SHARE
-
- Close
- Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases
-
Cho H, Cho Y, Cho EJ, Lee JH, Yu SJ, Oh KH, Lee K, Mustika S, Yoon JH, Kim YJ
- KMID: 2373127
- Clin Mol Hepatol.
- 2016 Jun;22(2):286-291.
- doi: 10.3350/cmh.2015.0066
Tenofovir disoproxil fumarate (TDF) is effective against chronic hepatitis B (CHB) infection and its use is increasing rapidly worldwide. However, it has been established that TDF is associated with renal... -
- CITED
-
- Close
- SHARE
-
- Close
- The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
-
Kim JH, Ahn SH, Ko SY, Choe WH, Kim KH, Kwon SY
- KMID: 2373120
- Clin Mol Hepatol.
- 2016 Jun;22(2):241-249.
- doi: 10.3350/cmh.2015.0053
BACKGROUND/AIMS: Before tenofovir (TDF) become available in South Korea, combination therapy with entecavir (ETV) and adefovir (ADV) was the most potent regimen for chronic hepatitis B (CHB) patients who fail... -
- CITED
-
- Close
- SHARE
-
- Close
- Drug-induced liver injury caused by iodine-131
-
Kim CW, Park JS, Oh SH, Park JH, Shim HI, Yoon JW, Park JS, Hong SB, Kim JM, Le TB, Lee JW
- KMID: 2373124
- Clin Mol Hepatol.
- 2016 Jun;22(2):272-275.
- doi: 10.3350/cmh.2015.0037
Iodine-131 is a radioisotope that is routinely used for the treatment of differentiated thyroid cancer after total or near-total thyroidectomy. However, there is some evidence that iodine-131 can induce liver... -
- CITED
-
- Close
- SHARE
-
- Close
- Bone marrow metastasis presenting as bicytopenia originating from hepatocellular carcinoma
-
Hong YM, Yoon KT, Cho M, Kang DH, Kim HW, Choi CW, Park SB, Heo J, Woo HY, Lim W, Bakhtiar UI Islam SM
- KMID: 2373123
- Clin Mol Hepatol.
- 2016 Jun;22(2):267-271.
- doi: 10.3350/cmh.2015.0017
The bone is a common site for metastasis in hepatocellular carcinoma (HCC). However, bone marrow metastasis from HCC is rarely reported, and its frequency is unclear. Here we report a... -
- CITED
-
- Close
- SHARE
-
- Close
- Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
-
Kim JY, Sinn DH, Gwak GY, Choi GS, Saleh AM, Joh JW, Cho SK, Shin SW, Carriere K, Ahn JH, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW
- KMID: 2373121
- Clin Mol Hepatol.
- 2016 Jun;22(2):250-258.
- doi: 10.3350/cmh.2016.0015
BACKGROUND/AIMS: Several studies have suggested that surgical resection (SR) can provide a survival benefit over transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) at the intermediate stage according to the Barcelona... -
- CITED
-
- Close
- SHARE
-
- Close
